AKT1 and breast cancer: The mammalian target of rapamycin (mTOR) is important in the extracellular and intracellular signals.17, 18 The mTOR pathway is downstream of PI3K/Akt, a well‐known pathway mainly out of regulation in cancer, which is also involved in BC.19